August 16, 2016
JACKSONVILLE, Fla.–(BUSINESS WIRE)–NovaBone Products, a leading biologics medical device company, today announced that it has received the Brazilian ANVISA Good Manufacturing Practices (GMP) medical device certificate. ANVISA is Brazil’s equivalent to the U.S. Federal Drug Administration (FDA), and is responsible for the oversight of all medical device and pharmaceuticals in the Brazilian market. The entire portfolio of NovaBone dental and orthopedic products is now available for Brazilian distribution.
“This important certificate extends our distribution to the largest market in South America,” said Art Wotiz, President of NovaBone Products. “The ANVISA GMP medical device certificate is another recognition of our commitment to quality and developing safe and effective leading-edge products for the global market.”
NovaBone is a privately held company based in Florida, USA since 2002. NovaBone developed the first bioactive synthetic bone graft offered to the orthopedic community and has long been at the forefront of bioactive glass bone graft devices. More recently, NovaBone established core competency in collagen devices. In total, NovaBone Products produces seven devices within the field of orthopedics and six for dental indications providing the medical community with unparalleled versatility and the widest range of choices in the bone graft device market.
Arthur Wotiz, 904-651-0607